Viewing Study NCT06732856


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2025-12-28 @ 1:38 AM
Study NCT ID: NCT06732856
Status: RECRUITING
Last Update Posted: 2025-07-28
First Post: 2024-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
Sponsor: Asan Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module